» Articles » PMID: 482734

In Vitro Studies on Resealed Erythrocyte Ghosts As Protein Carriers

Overview
Date 1979 Jul 20
PMID 482734
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Resealed erythrocyte ghosts have been proposed as in vivo carriers for enzyme replacement therapy of inherited metabolic diseases. In comparative studies of methods for reversible hypotonic haemolysis of erythrocytes, a five-fold increased entrapment of human serum albumin was obtained by use of a dialysis procedure instead of direct dilution. The percentage incorporation of protein was also affected by varying mixing procedure, haematocrit, lysis, and resealing times but not by varying buffer composition or added protein concentrations over a wide range. Higher protein entrapment was observed with time-expired blood compared to fresh blood and this may be ascribed to increased osmotic fragility of the erythrocyte membrane in stored cells. Haemolysed and resealed ghosts prepared by any method used were smaller than normal erythrocytes as measured with a Coulter Counter and with a fluorescence-activated cell sorter, and protein entrapment reduced the ghost size further.

Citing Articles

Engineering antiphagocytic biomimetic drug carriers.

Sawdon A, Peng C Ther Deliv. 2013; 4(7):825-39.

PMID: 23883126 PMC: 3919148. DOI: 10.4155/tde.13.54.


Organic-acid transport in resealed haemoglobin-containing human erythrocyte 'ghosts'.

Hubbard A, Sprandel U, Chalmers R Biochem J. 1980; 190(3):653-8.

PMID: 7470074 PMC: 1162143. DOI: 10.1042/bj1900653.


Towards enzyme therapy using carrier erythrocytes.

Sprandel U, Hubbard A, Chalmers R J Inherit Metab Dis. 1981; 4(2):99-100.

PMID: 6790867 DOI: 10.1007/BF02263610.


Laboratory-scale finned-rotor impeller for dialysis.

Nasser A Med Biol Eng Comput. 1989; 27(5):520-4.

PMID: 2622234 DOI: 10.1007/BF02441472.